News

Number of NSQ drugs has declined considerably in Gujarat during the last 10 years: Dr H G Koshia: Shardul Nautiyal, Mumbai ...
AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab has been approved in the European Union (EU) for the treatment of adult patients with previously untreated mantle ...
Specialization in B Pharm will increase job opportunities for pharmacy graduates: Dr Deependra Singh: Peethaambaran Kunnathoor, Chennai Wednesday, May 7, 2025, 08:00 Hrs [IST] Dr ...
Indian healthcare sector notes rise of AI in operating theatres transforms surgical interventions: Nandita Vijayasimha, Bengaluru Wednesday, May 7, 2025, 08:00 Hrs [IST] Indian he ...
The DTAB has ratified the notification issued by the Centre in February, extending the timeline for implementation of the revised Schedule M manufacturing standards for manufacturers having turnover ...
Yashoda Medicity introduces Elekta Unity MR Linac with integrated CMM: Our Bureau, Mumbai Tuesday, May 6, 2025, 12:50 Hrs ...
Novavax announces significantly improved terms for collaboration and license pact with Takeda for Nuvaxovid in Japan: Gaithersburg, Maryland Tuesday, May 6, 2025, 14:00 Hrs [IST] ...
Vanda Pharma announces Bysanti NDA with US filing; US FDA decision expected in early 2026: Washington Tuesday, May 6, 2025, 18:00 Hrs [IST] Vanda Pharmaceuticals Inc. (Vanda) anno ...
Neurocrine Biosciences announces new survey revealing need for routine screening and earlier diagnosis for people living with tardive dyskinesia: San Diego Tuesday, May 6, 2025, 1 ...
NRx Pharma files patent application for NRX-100, its proprietary, preservative free formulation of IV ketamine: Wilmington, Delaware Tuesday, May 6, 2025, 17:00 Hrs [IST] NRx Phar ...
Johnson & Johnson announces new data from Tremfya phase 3 QUASAR LTE study in adults with moderately-to-severely active ulcerative colitis: San Diego, California Tuesday, May 6, 2 ...